Matches in Nanopublications for { ?s ?p "[Examination of sera from patients with Lyme disease revealed that antibodies to P22 are rarely detected in patients with early-stage disease characterized by erythema migrans (2 of 20), and 35% of the patients with late-stage disease characterized by arthritis (9 of 26) developed antibodies to P22.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP1330229.RA2amJ0A-o-PQFhOQ0j_m9pOpkPzNFuTHB6216Wm4c5TA130_assertion description "[Examination of sera from patients with Lyme disease revealed that antibodies to P22 are rarely detected in patients with early-stage disease characterized by erythema migrans (2 of 20), and 35% of the patients with late-stage disease characterized by arthritis (9 of 26) developed antibodies to P22.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1330229.RA2amJ0A-o-PQFhOQ0j_m9pOpkPzNFuTHB6216Wm4c5TA130_provenance.
- NP1330230.RAXPezJf75lfWwulqxv7oIB39cUzYHwmHyTwWzBv2Znko130_assertion description "[Examination of sera from patients with Lyme disease revealed that antibodies to P22 are rarely detected in patients with early-stage disease characterized by erythema migrans (2 of 20), and 35% of the patients with late-stage disease characterized by arthritis (9 of 26) developed antibodies to P22.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1330230.RAXPezJf75lfWwulqxv7oIB39cUzYHwmHyTwWzBv2Znko130_provenance.
- NP1330228.RAIGPDmDcYtpWpTVPgGROGdPMthHcTIp7eoyjnV7PfAhc130_assertion description "[Examination of sera from patients with Lyme disease revealed that antibodies to P22 are rarely detected in patients with early-stage disease characterized by erythema migrans (2 of 20), and 35% of the patients with late-stage disease characterized by arthritis (9 of 26) developed antibodies to P22.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1330228.RAIGPDmDcYtpWpTVPgGROGdPMthHcTIp7eoyjnV7PfAhc130_provenance.
- NP1330231.RANOlcraUq0OIRyxXypHSeQbgN58oJZGg8Mtctz3jGK5c130_assertion description "[Examination of sera from patients with Lyme disease revealed that antibodies to P22 are rarely detected in patients with early-stage disease characterized by erythema migrans (2 of 20), and 35% of the patients with late-stage disease characterized by arthritis (9 of 26) developed antibodies to P22.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1330231.RANOlcraUq0OIRyxXypHSeQbgN58oJZGg8Mtctz3jGK5c130_provenance.